Alpine Global Management, LLC Biogen Inc. Transaction History

Alpine Global Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $540,230 - $680,662	-2,788 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $624,288 - $802,302	2,788 New	2,788 $669,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $510,741 - $589,714	-1,929 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $498,955 - $660,778	1,929 New	1,929 $516,000
Q1 2020 Apr 09, 2020	SELL	$268.85 - $341.04 $3.4 Million - $4.32 Million	-12,665 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$220.06 - $304.07 $2.79 Million - $3.85 Million	12,665 New	12,665 $3.76 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $474,073 - $530,997	-1,541 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $433,252 - $508,052	1,541	1,541 $483,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.